NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









ViCentra

ViCentra

Private
UtrechtHealthcare & Life Scienceshttps://hellokaleido.com/

Last Round

Series D

Extension

Jan 8, 2026

Total Funding Raised

$207.4M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

ViCentra is a medical device company that develops and manufactures the Kaleido insulin patch pump system, a small and light wearable device designed for people with diabetes.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT

Business Model

B2C

Customer Profile

Hardware Sales, Hardware + Subscription

AI Layer

Application

Keywords

insulin pumppatch pumpwearable medical deviceautomated insulin deliveryAIDdiabetes managementhybrid closed-looprazor and blademedical hardwareinsulin therapyhealth IoTdigital healthCGM integrationmedtech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

ViCentra Comps

Public and private peers based on sector, stage, and business model.

ViCentra comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

ViCentra Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series D ExtensionJan 8, 2026
Series DSep 3, 2025
Series CDec 16, 2021
Corporate FundingJun 30, 2020
Series BJan 16, 2016

ViCentra Investors

Notable investors and investment history

ViCentra investors
InvestorRounds
Kreos CapitalCorporate Funding
Venturing TechSeries D, Series D Extension
EQT Life SciencesSeries C, Series D, Corporate Funding, Series B
Invest-NLSeries C, Series D, Corporate Funding
ROM Utrecht RegionSeries D, Series D Extension
Kreos CapitalCorporate Funding
Partners in EquitySeries D, Series C

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 16, 2026

    Kaleido insulin pump now immediately available for new users.

  • Apr 15, 2026

    Monthly visitors increased 84% MoM.

ViCentra Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

ViCentra Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about ViCentra's valuation, stock price, and market status.

Firmographic Details

HeadquartersUtrecht
Employee Range202
Year Founded2013
Last FundingJan 8, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.